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ABSTRACT
Introduction: Technology-mediated strategies have
potential to engage patients in modifying unhealthy
behaviour and improving medication adherence to
reduce morbidity and mortality from cardiovascular
disease (CVD). Furthermore, electronic tools offer a
medium by which consumers can more actively
navigate personal healthcare information.
Understanding how, why and among whom such
strategies have an effect can help determine the
requirements for implementing them at a scale. This
paper aims to detail a process evaluation that will (1)
assess implementation fidelity of a multicomponent
eHealth intervention; (2) determine its effective
features; (3) explore contextual factors influencing and
maintaining user engagement; and (4) describe
barriers, facilitators, preferences and acceptability of
such interventions.
Methods and analysis: Mixed-methods sequential
design to derive, examine, triangulate and report data
from multiple sources. Quantitative data from 3
sources will help to inform both sampling and content
framework for the qualitative data collection: (1)
surveys of patients and general practitioners (GPs);
(2) software analytics; (3) programme delivery records.
Qualitative data from interviews with patients and GPs,
focus groups with patients and field notes taken by
intervention delivery staff will be thematically analysed.
Concurrent interview data collection and analysis will
enable a thematic framework to evolve inductively and
inform theory building, consistent with a realistic
evaluation perspective. Eligible patients are those at
moderate-to-high CVD risk who were randomised to
the intervention arm of a randomised controlled trial
of an eHealth intervention and are contactable at
completion of the follow-up period; eligible GPs are the
primary healthcare providers of these patients.
Ethics and dissemination: Ethics approval has been
received from the University of Sydney Human
Research Ethics Committee and the Aboriginal Health
and Medical Research Council (AH&MRC) of New
South Wales. Results will be disseminated via scientific
forums including peer-reviewed publications and
national and international conferences.
Trial registration number: ANZCTR
12613000715774.
INTRODUCTION
Cardiovascular disease (CVD) is a major
global health problem and contributor to
the wider public health epidemic of chronic
diseases.1 Worldwide, CVD accounts for 48%
of non-communicable disease mortality, with
behavioural risk factors such as physical
Strengths and limitations of this study
▪ Evidence is growing that eHealth interventions
are effective for supporting lifestyle behaviour
change, medication adherence and engaging
patients in healthcare navigation through shared
record systems.
▪ In this project, we will use a mixed-methods
approach to conduct a process evaluation of a
randomised controlled trial (RCT) testing a
consumer-focussed eHealth intervention for car-
diovascular disease risk reduction, integrated
with the primary healthcare electronic health
record.
▪ Findings will contribute new knowledge about
the important components for uptake, retention
and impact; also factors affecting transferability
to prevention strategies for other chronic
diseases.
▪ Potential limitations are that some qualitative
data will be collected before the RCT outcomes
are known, and thus one or more factors influen-
cing the trial results may be under-represented
in these data.
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inactivity, poor dietary habits, tobacco use and medica-
tion non-adherence noted as key modiﬁable causes.2 3
As the leading underlying cause of death for
Australians,4 CVD is a national priority for disease pre-
vention and healthcare cost reduction.5 CVD risk man-
agement is determined by the patient’s overall or
absolute CVD risk and the reduction of modiﬁable risk
factors.6 Pharmacotherapy and lifestyle risk factor reduc-
tion decreases CVD morbidity and mortality, in primary
prevention as well as in those with established CVD (sec-
ondary prevention).7 International data indicate that for
those with established CVD, uptake of traditional sec-
ondary prevention programme approaches is typically
low and only a minority attend an outpatient cardiac
rehabilitation programme after hospital discharge.8–11
However, more than 80% of the Australian population
visits a general practitioner (GP; synonymous here with
the term ‘primary care physician’) at least once each
year12 and more frequently as long-term health condi-
tions necessitate. Therefore, the primary healthcare
setting provides an opportunity for optimising reach of
behaviour change counselling13 and is where eHealth
approaches can complement clinician efforts to assist
patients with awareness and responsibility for health
behaviour modiﬁcation.14 15
Technology-based approaches also fulﬁl broader
national and international health system objectives to
engage consumers in healthcare through the use of
shared personal electronic records and decision-making
support.16 These innovations are increasingly being
recognised for their potential for more personalised
care navigation that may engage consumers in health
behaviour change. Such interventions offer alternative
approaches to print-based or face-to-face formats for
increasing access, uptake and engagement with effective
CVD prevention. eHealth is deﬁned as the use of infor-
mation technologies to improve health, healthcare deliv-
ery and healthcare information systems.17 18 The success
of such interventions has been reported in randomised
controlled trials (RCTs) targeting speciﬁc behaviours,
for example, increasing physical activity19 20 and
smoking cessation;21 22 or targeting multifactorial
aspects of lifestyle behaviour.23–25 In a description of the
role of social cognitive theory in health promotion and
disease prevention, Bandura26 suggests that using inter-
active technologies to ﬁrst tailor communication about
an individual’s relevant personal factors, then to enable,
motivate and guide, may enhance efforts to make life-
style changes.
The Consumer Navigation of Electronic
Cardiovascular Tools (CONNECT) RCT, has been
described previously.27 It tests a multicomponent, tai-
lored eHealth intervention to help patients adopt or
increase healthy behaviours and medication adherence
to improve CVD risk factor control. The primary end
point is a composite of the proportion of patients whose
blood pressure and fasting low-density lipoprotein chol-
esterol are meeting Australian guideline targets. The
intervention was developed in a systematic user-centred
design process previously described.28 A patient-focused
web application, accessible via a mobile device or com-
puter, is integrated with the primary healthcare elec-
tronic health record (EHR), enabling personalised risk
factor data and interactive absolute CVD risk score calcu-
lation to be displayed, explained and updated via a visu-
ally engaging interface. Other elements include (1)
interactive tools and information resources; (2) optional
receipt of tailored healthy lifestyle tips and motivational
messages; (3) interactive goal setting, tracking and
virtual rewards; and (4) a social media/message board.
Complex health interventions have multiple interact-
ing components.29 30 Process evaluation can assist in
identifying the critical elements, or combination of ele-
ments, from among multiple intervention components
and any mediating or competing inﬂuences on their
implementation.31–33 Moreover, a process evaluation col-
lects data about programme delivery, receipt and setting
which are essential to understanding the social processes
that inﬂuence why a complex intervention does or does
not have its intended impact.32 34 For this reason,
process evaluations are increasingly reported in conjunc-
tion with RCT outcomes to explain impact and under-
stand implications for future use of the intervention.35–38
Therefore, identifying how, for whom and in what
contexts this type of intervention works will contribute
new knowledge about the implementation of multicom-
ponent, consumer-focussed eHealth interventions. In
this paper, we describe the evaluation plan (table 1) for
explaining programme process and effects, to assist with
interpreting the trial outcomes and determining the
important factors for programme scale up.
Process evaluation aims
1. Assess implementation ﬁdelity in terms of intended
content, reach, dose and duration of the interven-
tion; and the role and extent of mediating factors on
implementation ﬁdelity;
2. Determine which features of the eHealth interven-
tion function as effective triggers or opportunities for
impact on health behaviour;
3. Explore contextual factors inﬂuencing and maintain-
ing user engagement with the intervention;
4. Identify and describe barriers, facilitators, prefer-
ences and acceptability of an eHealth intervention
from the perspective of patients and GPs.
METHODS AND ANALYSIS
Design
A mixed-methods sequential design will be under-
taken.40 Quantitative and qualitative data will be col-
lected concurrently both during and at the end of the
trial intervention period; however, analysis of some rou-
tinely collected quantitative data will precede patient
sampling for qualitative data collection.41 Seven data
sources will be used. Qualitative data collection and
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Table 1 Intervention evaluation plan
Objective
Evaluation component
Data source
Fidelity
measure
Function of
programme
providers
Function of
programme
users
Factor influencing
future programme
scale up
1. 1.1 Assess implementation fidelity32 33 39 of the eHealth
intervention with respect to the intended programme plan:
a. The intervention content is delivered in the intended
manner and quality(Adherence to intervention concept) Content X – X Programme delivery records
Web programme analytics
b. Proportion of intended target audience that participates in
all or part of the intervention
Reach – X X Programme delivery records
Web programme analytics
c. The amount of the intervention components that were
provided to patients
Dose delivered X – X Programme delivery records
Web programme analytics
d. How much of the activities and components was read,
viewed or used for the intended duration? (Engagement of
patients; see also 1.2(d) below)
Dose received/exposure – X X Programme delivery records
Web programme analytics
e. For how long was the intervention implemented as
intended by the trial design? (Related to intervention
exposure)
Frequency and duration X – X Programme delivery records
1.2 Explain the role and extent of four factors that mediate
implementation fidelity33
a. Intervention complexity
b. Facilitation strategies of programme delivery staff
c. Quality of programme delivery
d. Participant responsiveness
▸ Moderating factors on the relationship between the
intervention and its impact on recipients
▸ Patient characteristics
▸ Programme delivery factors
X Programme delivery records
Patient survey
Focus groups
2. Determine the effective features of the intervention that function
as triggers or opportunities for impact on health behaviour
▸ Patient characteristics
▸ Personal beliefs and/or programme features as triggers
for behaviour change action
▸ Personal circumstances or healthcare experiences
affecting capacity to adopt new healthier behaviour
X Programme delivery records
Focus groups
Patient interviews
3. Explore contextual factors influencing and maintaining user
engagement with the intervention
▸ Patient characteristics
▸ Perceived benefit and relevance of the intervention
▸ Personal circumstances or healthcare experiences
affecting capacity to adopt or maintain healthier behaviour
▸ Intervention features used to adopt or increase healthier
behaviour
X Programme delivery records
Focus groups
Patient survey
Patient interviews
4. Identify and describe barriers, facilitators, preferences and
acceptability of an eHealth intervention from the perspective of
patients and GPs
▸ Patient characteristics
▸ Programme content and delivery factors
▸ Barriers and facilitators; relevance and acceptability of
eHealth strategies
X Programme delivery records
Focus groups
Patient survey
Patient interviews
GP interviews
GP survey
GP, general practitioner.
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reporting will be informed by the consolidated criteria
for reporting qualitative research (COREQ).42 We will
use the realistic evaluation framework43 to then describe
how, why and among whom the intervention works in
practice. In the realistic evaluation model, an interven-
tion per se does not cause the outcomes observed;
rather, one or more of its activities or components intro-
duces an idea or motivation or opportunity (the mech-
anism) into a social or cultural situation (context), the
combination of which may lead to an impact on behav-
iour (the observed outcome).44 In elucidating what
might work for whom, how and in what circumstances,
these concepts offer a ﬁtting perspective for process
evaluation because they focus less on the RCT effect
between those exposed and not exposed to the interven-
tion, and more on explaining context, mechanism and
outcome within the exposed group. Therefore, these
ﬁndings will inform intervention scale up and transfer-
ability because they increase understanding about
characteristics of populations more likely to beneﬁt.
The evaluation will be structured around the logic
model outlined in ﬁgure 1. A logic model sets out the
relationship between constructs of interest and mediat-
ing inﬂuences within a change process, namely the pro-
gramme resource inputs, the activities or processes they
produce, and the outputs that lead to the programme
outcomes.45 46 For the CONNECT intervention, the
logic model depicts the intended inputs, activities,
outputs and impact of the intervention as follows:
(1) resource inputs (the web application integrated with
the EHR and the human resources required to imple-
ment it); (2) processes and activities of these inputs (the
clinical and technical support from staff and the perso-
nalised and interactive features within the intervention;
(3) intervention outputs (patient use both of interven-
tion components and staff support options); and (4)
impact on patients of exposure to the intervention
(adoption of healthier lifestyle choices and more pro-
active engagement with the healthcare experience).
Core characteristics of implementation ﬁdelity (content,
dose delivered, dose received) are shown as correspond-
ing to speciﬁc sections of the logic model. Similarly, four
mediating factors on ﬁdelity (intervention complexity,
facilitation strategies used by programme delivery staff,
quality of delivery and patient responsiveness)33 are
shown at their probable point(s) of inﬂuence. The
relationship between these core characteristics and
mediating factors will strengthen understanding about
how programme effects happened—an important
consideration in transferability and dissemination in
other settings.32
Participants
Intervention arm patients and their GPs are eligible for
participation in the process evaluation. Consenting
patients (age >18 years) with established CVD or at
moderate-to-high risk of a CVD event based on criteria
outlined in the trial protocol will be included.27
Figure 1 Logic model for Consumer Navigation of Electronic Cardiovascular Tools (CONNECT) implementation evaluation.
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Patients must be available in person or by telephone for
the month 12 study follow-up visit and willing to provide
written, informed consent to take part in either a focus
group discussion or an interview (not both). Limiting
patients to one format is intended to minimise
responder burden and potentially duplicative conversa-
tions. Each format, however, has a distinct purpose in
respect of data that is appropriate to group conversation
versus personal or conﬁdential topics. To avoid contam-
inating the intervention, patients will be invited to
respond to the survey, and to take part in either a focus
group or an interview, only after completion of the
12-month follow-up period. Consenting GPs will need to
be the nominated primary healthcare provider for at
least one RCT patient.
Data sources
Web programme analytics
Two methods will examine patients’ direct interaction
with the intervention. First, web page ‘tagging’ has been
applied to the website to systematically record aspects of
usage by patients during the study follow-up period.
Tagging is a data source that logs user interaction with
in-app features. It will provide real-time and historical
ﬁgures about engagement with key interactive screens:
absolute CVD risk calculator; counts of monthly perso-
nalised goal setting and goals achieved, and access of
the message board/chat forum. These data enable
researchers to identify whether portal login and use is
sustained, declines or ﬂuctuates over the timeline of
follow-up. These metrics are independent of patients’
self-reported use of the programme; they will both assist
with sampling diverse patients for the qualitative data
collection, and augment data from the patient surveys
and focus groups to inform understanding of pro-
gramme appeal and attrition. Separately, a customised
tracker counts the motivational and healthy lifestyle tips
sent to patients by email and/or short message service.
Since patients can opt out of receiving these messages,
these data will help describe the interest in this feature
of the intervention. Second, data about the number of
unique monthly website login sessions on three device
types (laptop computer, tablet or Smartphone) will be
obtained from a commercial web analytics service
(Google Analytics).
Programme delivery records
Database records maintained by study staff record the
number of intervention arm patients who were trained
to use the eHealth programme (informing programme
reach); any facilitation strategies that enabled patients to
more easily use the intervention (maximising reach and
dose received); and the content, duration and format of
scheduled and ad hoc communication during the
follow-up period (considerations for intervention dur-
ation, dose received and staff skill mix needs). Feedback
offered by patients during communication with staff is
categorised and quoted (anonymously), providing
additional contextual data. The nature of technical or
content errors in a patient’s app that are identiﬁed and
ﬁxed prior to training or during follow-up is recorded,
ensuring that intended content within the app, for
example, data imported from the EHR, is correct (maxi-
mising dose delivered). As indicated, these records both
reﬂect programme delivery quality and will complement
data about implementation ﬁdelity, namely: (1) propor-
tion of intended patients who actually took part (reach);
(2) the extent of patient uptake of the intervention
(dose received); (3) the extent that all components of
the intervention were delivered as frequently and for as
long as planned (dose delivered and duration);33 39 and
(4) intervention delivery time requirements (important
for resource needs assessment in sustaining or upscaling
such an intervention).
Survey of patients
Eligible patients will be invited to complete a short
survey at the ﬁnal study follow-up visit, thereby minimis-
ing recall bias. Patients will be asked to complete their
survey in conﬁdence; the survey will be mailed to those
unable to attend the month 12 study visit in person. The
two-page survey includes 10 statements with Likert scale
responses about use of various features of the interven-
tion (such as goal setting and tracking, receipt of motiv-
ational lifestyle tips, and charting weight or other
measurements), and effect on healthy behaviours (such
as weekly physical activity, eating habits, medication
adherence); six questions have categorical responses
about ease and frequency of use of the intervention and
access to study staff for support; and three questions
allow free-text responses about programme utility and
preferred features/screens. Our previous work in testing
the concept and design of the intervention28 informed
the choice of content for which feedback is sought;
general guidelines for questionnaire design were then
used to develop a reliable survey.47 It was reviewed for
content validity by the multidisciplinary research team
(nurses, physiotherapist, GPs) with expertise in instru-
ment design and familiarity with the intervention.
Focus group discussions
Eligible patients will be invited by telephone, postal or
email invitation to take part in focus groups of ∼8–10
people per group. A minimum of three focus groups
will be conducted at locally available or participating
health service facilities for ∼1 hour duration per group.
We will use the software analytics data to enable a diver-
sity sampling approach to the mix of patients in terms of
age, sex, CVD risk status and frequency of intervention
usage, the latter metric being of particular interest as a
variable associated with clinical outcome. Recruitment
for focus groups will be consecutive until no new themes
or categories emerge (thematic saturation); however, it
is anticipated that at least 25–30 people will be invited to
take part. Standard focus group methods will be used
including facilitation by a trained health professional
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with knowledge of the RCT, a non-participant observer/
note-taker, setting of ground rules and audio record-
ing.48 A discussion guide will expand on key feedback
themes from the patient survey, including usability and
use of the intervention, perceived quality of delivery and
programme support; preference for duration of pro-
gramme participation; potential improvements or
changes to the intervention components; and important
or relevant features that impacted behaviour or changed
how the patient engaged with their GP or other health-
care services regarding their care. The emphasis of
focus groups is therefore on feedback about practical
implementation issues that are appropriate to a group
conversation, rather than targeted to personal health
information or circumstances.
Interviews with patients
Eligible patients will be invited by telephone, postal or
email invitation to take part in a one-on-one interview of
up to 1 hour duration. Interviews will explore personal
and potentially sensitive topics that are inappropriate for
a focus group format. The researcher will ask the inter-
viewee about his/her responses to the content and
options offered within the eHealth intervention; their
subsequent choices about making lifestyle-related
changes, and their capacity for action within their per-
sonal circumstances. Within the realistic evaluation
model, the purpose of interviews is to use the patient’s
experience of the programme to test a hypothesis about
how and why intervention components create an oppor-
tunity for behaviour change; and from these responses
build understanding about the characteristics and con-
texts of users for whom this happens. Interviews with
programme users are the key data source in constructing
data within this framework.43 The researcher thus pro-
poses a ‘theory’ about programme mechanisms acting in
the patient’s personal context or circumstances to cause
an impact/outcome, and seeks the interviewee’s reﬁne-
ment of this proposal, by falsifying or conﬁrming the
ideas through telling their own story.43 49 Important dif-
ferences in contextual factors, for example, socio-
economic status, risk factor awareness, lifestyle and social
support that affect decision-making and promote or
hinder programme uptake may therefore be identiﬁed.
Data within the routinely collected software metrics will
assist us using a maximum variation sampling method
based on patient demographics, CVD risk status, and the
type and frequency of use of intervention features.
Sampling will continue until thematic saturation is
achieved. Interviews will be conducted at locally available
or participating health service facilities or general prac-
tices; at the George Institute or via telephone, as con-
venient for the patient. A semistructured interview guide
will be used by a trained health professional to conduct
the interview and audio recording will ensure important
verbal data are captured. Notes may be made by the
researcher after the interview to document relevant non-
verbal information.
Survey of GPs
All GPs taking part in the RCT will be invited by mail,
email and/or direct phone contact to complete a survey
at the end of the study. The aim is to obtain feedback
about their experience of the RCT set-up and conduct
in their workplace, and of using the software required to
facilitate the shared health record innovation. Also of
interest are their usual strategies for lifestyle modiﬁca-
tion counselling for their patients with moderate or high
CVD risk, and their perception of relevance and beneﬁt
of eHealth approaches. The two-page survey of 19 ques-
tions will include 6 questions requiring Likert scale
responses (related to research participation); 2 allowing
multiple response selection (related to research partici-
pation and to lifestyle counselling preferences); 5 with
categorical responses (related to programme content
and impact on their patients); and 6 allowing free-text
comments (related to perceptions of beneﬁt and draw-
backs). Content targets feedback agreed by the research
team to be important to future dissemination of an
eHealth strategy that is integrated with GP medical
record software systems. General guidelines for question-
naire design were then used to develop a reliable
survey.47 It was reviewed for content validity by the multi-
disciplinary research team (nurses, physiotherapist, GPs)
with expertise in instrument design and understanding
of the general practice environment. The survey will be
sent by email, or postal mail with a return addressed
envelope, and telephone follow-up will ensure
maximum number of surveys are returned.
Interviews with GPs
GPs participating in the RCT will be invited by email or
postal mail to take part in a conﬁdential one-on-one
interview at the end of the study. The purpose of inter-
views is to: expand on themes within the survey so as to
triangulate these data; explore their previous and
current experiences with eHealth strategies; gain
insights about patient characteristics affecting choices
made about behaviour change support; describe per-
ceived beneﬁts, barriers or concerns from using the inte-
grated health record software, or from GP–patient
interactions about the intervention’s content or impact.
Combining the interview data with those from the feed-
back surveys will enable a richer GP perspective on pro-
gramme utility, equity, barriers and likelihood of
adoption. Given that linkage with the primary health-
care software is central to this intervention, these data
will inﬂuence appraisal of sustaining and scaling up
such a strategy. We anticipate that interviews with a con-
secutive sample of ∼10 participating GPs from different
suburban locations reﬂecting diverse patient demog-
raphy will be sufﬁcient; however, we will continue to
recruit until we achieve thematic saturation. A trained
healthcare professional will conduct and audio record
the interviews of ∼30 min duration at the practice or
health service, or via telephone, as convenient for the
GP. A discussion guide of open-ended questions will be
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used. Notes may be made by the researcher after an
in-person interview to document relevant non-verbal
information.
Data analysis
The website server logs will be analysed for frequency of
logins by patients and number of visits to speciﬁc pages;
also the number and delivery format of lifestyle message
tips. Program analytics data will be presented as fre-
quencies and proportions to enable description of user
engagement with the intervention generally and with
speciﬁc interactive features, for example, social media
forum and goal tracking. Process measures (reach, dose
and duration of the intervention) will be analysed as
proportions, frequencies and means. Subgroup analyses
will assess for any differential impact of the intervention
on RCT outcome measures by extent of uptake of the
intervention. Statistical signiﬁcance will be assessed
using χ2 tests for categorical variables and t-tests for con-
tinuous variables. Univariate and multivariate regression
models will be built to determine associations between
various exposure variables and the prespeciﬁed trial
outcomes. Descriptive statistics will be derived from the
survey responses and will be reported as frequencies
and proportions; for example, the type and extent of
engagement with key intervention features; likes and
dislikes about the programme; perceived impact of, and
overall views about, the role of an EHR-integrated
intervention to support CVD risk factor reduction, and
so on.
Feedback from patients within telephone and email
communication during the study follow-up period will
be categorised and quotations noted. These add to the
programme feedback from survey and focus groups data
and offer insight into characteristics of patients for
whom the intervention did or did not appeal. For the
focus group and interview data, a minimum of two
researchers will independently conduct thematic analysis
of transcripts. Using the constant comparison method,
codes will be identiﬁed inductively based on emergent
themes.50 Reporting of these data will be guided by the
COREQ guidelines.42 An inductive approach will also be
taken to analysis of any textual responses within the
patient and GP surveys, and in the records of patient
contact with programme staff. Concurrent interview data
collection and analysis will enable a thematic framework
to evolve inductively and help inform theory building
about the intervention from a realistic evaluation per-
spective. Integration of qualitative and quantitative ana-
lyses will thus occur at multiple phases in the evaluation,
from sampling of patient interviewees, for example, to
the broader analysis and interpretation. Results from
our different data sources will be integrated and inter-
preted to improve validity of conclusions. We will use
tools from recognised implementation frameworks51 52
to support our analyses and reporting of the data.
Particular emphasis will be placed on any divergent ﬁnd-
ings that arise.41
ETHICS AND DISSEMINATION
Clinical Trial Agreements are signed between participat-
ing primary healthcare services and the George Institute
for Global Health, Australia. Patients and GPs who are
invited to participate in a focus group or interview will
be provided with an information sheet explaining its
purpose and conduct and asked to provide written
informed consent before taking part. Results of this
research will be disseminated via scientiﬁc forums
including peer-reviewed publications and presentations
at national and international conferences.
DISCUSSION
Two key process questions for a complex health interven-
tion are to understand its mechanisms of impact and
the context(s) in which the impact occurs.29 This
process evaluation plan addresses these questions for a
technology-based intervention designed to inﬂuence
patient attitudes and/or behaviour in respect of
lifestyle-related CVD risk factors and navigation of their
wider healthcare experience. Realistic evaluation is a
framework with which to examine complex programmes
in these terms. Furthermore, explaining programme
process and effects assists in interpreting the trial out-
comes and determining the important factors for pro-
gramme scale up and dissemination.
Multiple dimensions of engagement with an eHealth
intervention are therefore important to characterise:
behavioural (what the person does); cognitive (what the
person knows and understands) and emotional (what
the person feels about their disease and steps to manage
it).53 54 No single metric describes website engagement.
Page visits, time spent and interactive components used
are relatively accessible measures. Little is known,
however, about user characteristics that inﬂuence
engagement in respect of the above three dimensions
for an intervention such as this one, and which may
inform understanding about the programme compo-
nents that drive ongoing participation versus foreseeable
programme attrition. In turn, the relationship between
programme engagement and user impact may illumin-
ate the threshold level of involvement that confers a
beneﬁt to patients—the assumption being that website
use at best ﬂuctuates, but diminishes over time.55 This
process evaluation will explore these questions of
meaning, social context and characteristics of those for
whom the intervention was or was not helpful. Further,
survey and qualitative data will address usability, overall
user experience and social validity that gauge consumer
acceptance of web-based interventions.56
The questions of interest described in this research
concern ﬁdelity of implementation, how and for whom
the intervention works, and thus what inﬂuences future
scale up, expansion or transferability of such a pro-
gramme. We have therefore incorporated selected report-
ing criteria from the Reach, Effectiveness, Adoption,
Implementation, and Maintenance (RE-AIM) evaluation
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framework51 as apply to this study, although the research
is not explicitly modelled on this. Each of the above ﬁve
dimensions within RE-AIM comprise multiple reporting
criteria which previous studies have reported to varying
degrees, often to the exclusion of qualitative methods.57
We are targeting pertinent criteria within the dimensions
of reach, effectiveness and implementation; for example,
percentage of individuals who take part (R), qualitative
data to understand lifestyle behaviour change outcomes
(E), and programme delivery measures (I), respectively.
Mixed-methods data collection is a methodological
strength for exploring process questions within the RCT
because both qualitative and quantitative data from
patients and GPs will enable richer complementary
insights than from either method alone.41 50 A systematic
mapping review of qualitative inquiry within RCTs into
aspects of intervention delivery underscored the advan-
tage both to interpreting trial ﬁndings and improving
external validity.58 A potential limitation of this evaluation
process is that data from surveys, focus groups and inter-
views may be subject to recall bias when obtained after
12 months of study follow-up; we did not undertake
formal validity and reliability testing of the surveys.
Adherence is likely to have at best ﬂuctuated over that
period; thus, recall bias may favour the later over the
earlier months of using the intervention. Also, without
prior knowledge of the RCT outcome, some uncertainty is
possible about the content or topics on which to focus
aspects of the data collection that precede trial comple-
tion; however, analysis of these data will likely occur when
trial outcome data are available. Timing the process evalu-
ation data collection ahead of RCT outcome analysis may
also risk that unanticipated trial outcomes will be under-
recognised in the process data.34 On the other hand, the
many intervention components reﬂect principles of per-
suasive software system design and social cognitive theory;
therefore, combining these development inﬂuences with
the concepts explored in realistic evaluation enables this
evaluation to have a more deﬁned than speculative focus.
CONCLUSION
Evidence is growing that eHealth interventions are effect-
ive for improving lifestyle behaviours associated with
development and progression of chronic diseases. At-risk
patients and their primary healthcare providers are key
to our understanding about the role of these innovative
approaches in primary and secondary CVD prevention.
Expansion of eHealth as a medium for public health
interventions can beneﬁt from reporting of how they
interact both with contextual factors and any possible
moderating inﬂuences of their component features or
delivery methods.59 60 A complex eHealth intervention
designed for health behaviour change support is best
understood by process evaluation research about pro-
gramme ﬁdelity (how the intervention delivery compared
with the intended protocol); and how, and for whom, the
intervention triggers intent and action for behaviour
change within the recipient’s circumstances and care
experience (the mechanisms and context explained by
realistic evaluation). Taken together, these process data
will expand and enrich understanding of RCT results and
may inform transferability to prevention programmes for
other chronic conditions in which lifestyle-related factors
drive disease risk.
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